SHELTON, CT / ACCESS Newswire / July 22, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that ...
SHELTON, CT / ACCESS Newswire / July 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...
Jyong Biotech Ltd. (Nasdaq: MENS) (the 'Company” or 'Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ...
Arch Biopartners Inc. today announced that it has engaged a U.S.-based laboratory specializing in bioengineering to accelerate the Company's pre-IND IL-32 chronic kidney disease ("CKD") program. The U ...
Azio AI Holdings, Inc. (the "Company") today announced that its common stock will begin trading under the new ticker symbol "AZIO" on The Nasdaq Capital Market at the open of trading on Monday, July ...
Drug companies have quietly stepped back from development programs in long COVID and related conditions, leaving patients ...
Detailed price information for Nanoviricides Inc (NNVC-A) from The Globe and Mail including charting and trades.
OpenAI API costs can spiral when agents run wild. Here's how to set spend limits, enable hard caps, and avoid surprise AI bills.
New York City Mayor Zohran Mamdani may not use ChatGPT, but his agencies have adopted chatbots and other artificial ...
July 16 (Reuters) - Prediction market platform Kalshi will start taking bets on the outcomes of clinical trials and FDA ...
Mayo Clinic, one of the world’s most well-known hospital systems, is using AI in hopes of improving patient care and, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results